Calmodulin kinase II, sarcoplasmic reticulum Ca2+ leak, and atrial fibrillation

Trends Cardiovasc Med. 2010 Jan;20(1):30-4. doi: 10.1016/j.tcm.2010.03.004.

Abstract

Although it is generally accepted that excitation-contraction coupling is defective in patients with atrial fibrillation, the underlying cellular mechanisms remain incompletely understood. Recent studies suggest that abnormal sarcoplasmic reticulum calcium "leak" via ryanodine receptors contributes to atrial arrhythmogenesis. Increased activity of the enzyme calmodulin kinase II (CaMKII) and, specifically, enhanced CaMKII phosphorylation of ryanodine receptors appear to play a critical role in the induction and perhaps maintenance of atrial fibrillation. In this review, we will summarize new insights into the role of enhanced CaMKII in sarcoplasmic reticulum calcium leak and atrial arrhythmogenesis during atrial fibrillation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-Arrhythmia Agents / therapeutic use
  • Atrial Fibrillation / drug therapy
  • Atrial Fibrillation / enzymology*
  • Atrial Fibrillation / physiopathology
  • Calcium / metabolism*
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / antagonists & inhibitors
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism*
  • Enzyme Activation
  • Excitation Contraction Coupling* / drug effects
  • Heart Atria / enzymology
  • Heart Atria / physiopathology
  • Humans
  • Phosphorylation
  • Protein Kinase Inhibitors / therapeutic use
  • Ryanodine Receptor Calcium Release Channel / metabolism
  • Sarcoplasmic Reticulum / drug effects
  • Sarcoplasmic Reticulum / enzymology*

Substances

  • Anti-Arrhythmia Agents
  • Protein Kinase Inhibitors
  • Ryanodine Receptor Calcium Release Channel
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium